About this FactMed analysis covering adverse side effect reports of ALIZAPRIDE patients who developed HYPERSENSITIVITY.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking ALIZAPRIDE reported HYPERSENSITIVITY to the FDA. A total of 102 ALIZAPRIDE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALIZAPRIDE and HYPERSENSITIVITY. In doing so, we compare ALIZAPRIDE with other drugs that cause HYPERSENSITIVITY, to help you evaluate whether or not ALIZAPRIDE causes HYPERSENSITIVITY. Likewise, this page shows the most highly-reported side effects of ALIZAPRIDE, so you can see if HYPERSENSITIVITY ranks among ALIZAPRIDE's most well-known side effects.
Summary Statistics
Reports of ALIZAPRIDE causing HYPERSENSITIVITY: 2
Reports of any side effect of ALIZAPRIDE : 102
Percentage of ALIZAPRIDE patients where HYPERSENSITIVITY is a reported side effect: 1.9608%

FDA reports of any drug causing HYPERSENSITIVITY : 38869
Average percentage for all medicated patients where HYPERSENSITIVITY is reported as a complication: 0.2436%

Physician opinion on ALIZAPRIDE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALIZAPRIDE:
DRUG USE FOR UNKNOWN INDICATION ( 14 patients )
NAUSEA ( 14 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 3 patients )
PREMEDICATION ( 2 patients )
VOMITING ( 2 patients )
ANTIEMETIC SUPPORTIVE CARE ( 2 patients )
PROPHYLAXIS ( 1 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with HYPERSENSITIVITY:

FOSAMAX (2522 patients)
TYSABRI (2096 patients)
ASPIRIN (1762 patients)
HEPARIN SODIUM INJECTION (1590 patients)
REMICADE (1580 patients)
VIOXX (1330 patients)
ENBREL (1212 patients)
AVELOX (1109 patients)
LIPITOR (1105 patients)
HUMIRA (1060 patients)
SYNTHROID (953 patients)
LYRICA (935 patients)
CHANTIX (905 patients)
LISINOPRIL (861 patients)
AVONEX (851 patients)
PREDNISONE (841 patients)
BENADRYL (838 patients)
FORTEO (793 patients)
METHOTREXATE (791 patients)
NEXIUM (784 patients)
XOLAIR (752 patients)
OMEPRAZOLE (732 patients)
CELEBREX (725 patients)
ALBUTEROL (679 patients)
LASIX (633 patients)
SIMVASTATIN (627 patients)
ALEVE (624 patients)
ATENOLOL (611 patients)
ADVAIR DISKUS 100/50 (597 patients)
ACETAMINOPHEN (592 patients)
SINGULAIR (588 patients)
LEVOTHYROXINE SODIUM (572 patients)
NEURONTIN (571 patients)
FOLIC ACID (570 patients)
PLAVIX (569 patients)
IBUPROFEN (567 patients)
HYDROCHLOROTHIAZIDE (537 patients)
ZOLOFT (530 patients)
XANAX (525 patients)
NORVASC (504 patients)
SPIRIVA (489 patients)
PRILOSEC (477 patients)
ALEVE (CAPLET) (475 patients)
PREMARIN (469 patients)
TOPROL-XL (466 patients)
SEROQUEL (462 patients)
CYMBALTA (454 patients)
ZYRTEC (448 patients)
ZOCOR (417 patients)
DIOVAN (414 patients)
LEXAPRO (413 patients)
FUROSEMIDE (412 patients)
VITAMIN D (403 patients)
COUMADIN (402 patients)
CRESTOR (399 patients)
LEVAQUIN (398 patients)
PREDNISOLONE (397 patients)
LAMICTAL (394 patients)
METFORMIN HCL (390 patients)
NICODERM CQ (385 patients)
CARBOPLATIN (379 patients)
DEXAMETHASONE (361 patients)
PREVACID (355 patients)
ALLEGRA (349 patients)
ZANTAC (345 patients)
CALCIUM (343 patients)
LANTUS (342 patients)
GABAPENTIN (336 patients)
PROTONIX (333 patients)
AMOXICILLIN (332 patients)
DURAGESIC-100 (327 patients)
AMBIEN (324 patients)
PREDNISONE TAB (321 patients)
POTASSIUM CHLORIDE (319 patients)
ALLOPURINOL (316 patients)
VICODIN (307 patients)
MULTIHANCE (302 patients)
MULTI-VITAMINS (302 patients)
BYETTA (293 patients)
WELLBUTRIN (287 patients)
FLUOROURACIL (285 patients)
CLONAZEPAM (285 patients)
ZOFRAN (285 patients)
ATIVAN (284 patients)
WARFARIN SODIUM (280 patients)
SYMBICORT (276 patients)
LEVOXYL (275 patients)
RITUXIMAB (275 patients)
SOLU-MEDROL (275 patients)
KLONOPIN (272 patients)
AMLODIPINE (270 patients)
ERBITUX (270 patients)
TEGRETOL (269 patients)
ALENDRONATE SODIUM (268 patients)
LORAZEPAM (268 patients)
CLARITIN (264 patients)
EFFEXOR (257 patients)
DECADRON (255 patients)
PERCOCET (253 patients)
FOSAMAX PLUS D (253 patients)
XALATAN (252 patients)
ZETIA (252 patients)
PAXIL (252 patients)
FLONASE (251 patients)
VENTOLIN (251 patients)
ALPRAZOLAM (247 patients)
BEXTRA (247 patients)
TYLENOL (CAPLET) (246 patients)
ZITHROMAX (245 patients)
DOCETAXEL (243 patients)
METOPROLOL TARTRATE (242 patients)
ALL OTHER THERAPEUTIC PRODUCTS (239 patients)
TRAMADOL HCL (239 patients)
REBIF (239 patients)
BONIVA (238 patients)
TAXOL (236 patients)
OXYCONTIN (233 patients)
CYCLOPHOSPHAMIDE (232 patients)
PROZAC (230 patients)
PACLITAXEL (230 patients)
NIASPAN (229 patients)
RANITIDINE (224 patients)
HUMALOG (218 patients)
INSULIN (218 patients)
ACTONEL (217 patients)
PARACETAMOL (214 patients)
ELOXATIN (213 patients)
ACCUTANE (213 patients)
NITROGLYCERIN (210 patients)
REVLIMID (208 patients)
COZAAR (207 patients)
GAMMAGARD LIQUID (207 patients)
ASCORBIC ACID (207 patients)
MORPHINE (206 patients)
VITAMIN E (205 patients)
NASONEX (205 patients)
ZYPREXA (203 patients)
AZITHROMYCIN (202 patients)
TYLENOL (202 patients)
ENALAPRIL MALEATE (199 patients)
VANCOMYCIN (198 patients)
DIAZEPAM (196 patients)
AUGMENTIN '125' (195 patients)
BACTRIM (195 patients)
MULTI-VITAMIN (194 patients)
FLEXERIL (194 patients)
COPAXONE (194 patients)
HEPARIN SODIUM (193 patients)
OXALIPLATIN (192 patients)
FISH OIL (191 patients)
COREG (190 patients)
ZOMETA (188 patients)
GLUCOPHAGE (187 patients)
ADVIL (184 patients)
METFORMIN (183 patients)
GLIPIZIDE (183 patients)
MOTRIN (182 patients)
LANSOPRAZOLE (181 patients)
FLOVENT (181 patients)
DILANTIN (180 patients)
CIPROFLOXACIN (180 patients)
TRAZODONE HCL (179 patients)
OXYCODONE HCL (179 patients)
RAMIPRIL (178 patients)
VOLTAREN (177 patients)
HEPARIN (176 patients)
TOPAMAX (176 patients)
NOVOLOG (175 patients)
CELEXA (174 patients)
FENTANYL (173 patients)
NEULASTA (173 patients)
HYDROCORTISONE (170 patients)
DIGOXIN (169 patients)
COMBIVENT (169 patients)
GEODON (166 patients)
DEPAKOTE (166 patients)
CALCIUM (UNSPECIFIED) (165 patients)
EPOGEN (165 patients)
LORTAB (164 patients)
NAPROXEN (164 patients)
ARANESP (163 patients)
MABTHERA (163 patients)
VITAMIN B-12 (162 patients)
OMALIZUMAB (161 patients)
FENTANYL-100 (161 patients)
METOPROLOL SUCCINATE (161 patients)
AVASTIN (160 patients)
METOPROLOL (159 patients)
LOVENOX (159 patients)
ATORVASTATIN CALCIUM (158 patients)
TAXOTERE (157 patients)
PEPCID (157 patients)
LEUCOVORIN CALCIUM (156 patients)
PLAQUENIL (155 patients)
VALIUM (155 patients)
PULMICORT (155 patients)
ACYCLOVIR (153 patients)
GLEEVEC (152 patients)
VALTREX (151 patients)
MIRENA (150 patients)
AMITRIPTYLINE HCL (150 patients)
LOPRESSOR (150 patients)
ACETYLSALICYLIC ACID SRT (149 patients)
CLONIDINE (149 patients)
FAMOTIDINE (149 patients)
ACTOS (148 patients)
DIOVAN HCT (148 patients)
[THERAPY UNSPECIFIED] (146 patients)
ALTACE (146 patients)
GLYBURIDE (145 patients)
Most common side effects for patients taking ALIZAPRIDE:
DIARRHOEA (16 patients)
PYREXIA (16 patients)
VOMITING (10 patients)
FATIGUE (9 patients)
HYPOKALAEMIA (9 patients)
DEHYDRATION (8 patients)
NAUSEA (7 patients)
ANAEMIA (6 patients)
ASTHENIA (6 patients)
BRONCHOPNEUMONIA (6 patients)
DRUG INTERACTION (6 patients)
DYSPNOEA (6 patients)
HYPOTENSION (6 patients)
PNEUMONIA (6 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (5 patients)
HAEMORRHAGE (5 patients)
HYPOMAGNESAEMIA (5 patients)
HYPOPHOSPHATAEMIA (5 patients)
JAUNDICE (5 patients)
RESPIRATORY FAILURE (5 patients)
SOMNOLENCE (5 patients)
TACHYCARDIA (5 patients)
ABDOMINAL PAIN (4 patients)
ADVERSE DRUG REACTION (4 patients)
FALL (4 patients)
HAEMODIALYSIS (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
INTESTINAL OBSTRUCTION (4 patients)
MALAISE (4 patients)
SLEEP APNOEA SYNDROME (4 patients)
SUPRAVENTRICULAR TACHYCARDIA (4 patients)
THROMBOCYTHAEMIA (4 patients)
THROMBOCYTOPENIA (4 patients)
WHITE BLOOD CELL COUNT DECREASED (4 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (3 patients)
BACTERIAL SEPSIS (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
BLOOD CREATININE INCREASED (3 patients)
DECREASED APPETITE (3 patients)
DERMATITIS EXFOLIATIVE (3 patients)
DEVICE DISLOCATION (3 patients)
ENTERITIS (3 patients)
FEBRILE NEUTROPENIA (3 patients)
FIBRIN D DIMER INCREASED (3 patients)
FUSOBACTERIUM INFECTION (3 patients)
HAEMOPTYSIS (3 patients)
HYPOXIA (3 patients)
ILEUS (3 patients)
LEUKAEMIA RECURRENT (3 patients)
MUCOSAL INFLAMMATION (3 patients)
NEUROTOXICITY (3 patients)
NEUTROPENIA (3 patients)
OVERDOSE (3 patients)
PRESYNCOPE (3 patients)
PROTEUS INFECTION (3 patients)
RASH (3 patients)
RENAL FAILURE ACUTE (3 patients)
SEPTIC SHOCK (3 patients)
SUPERINFECTION (3 patients)
TONGUE DISORDER (3 patients)
ACUTE PULMONARY OEDEMA (2 patients)
AGRANULOCYTOSIS (2 patients)
ATRIAL FIBRILLATION (2 patients)
BLOOD FIBRINOGEN INCREASED (2 patients)
BLOOD GLUCOSE INCREASED (2 patients)
BONE MARROW DEPRESSION (2 patients)
BONE MARROW FAILURE (2 patients)
BRONCHOPULMONARY ASPERGILLOSIS (2 patients)
C-REACTIVE PROTEIN INCREASED (2 patients)
CHILLS (2 patients)
COLITIS ISCHAEMIC (2 patients)
CONSTIPATION (2 patients)
CONVULSION (2 patients)
CORONARY ARTERY DISEASE (2 patients)
DEAFNESS (2 patients)
DIZZINESS (2 patients)
DRUG ADMINISTRATION ERROR (2 patients)
DYSPHAGIA (2 patients)
DYSURIA (2 patients)
EJECTION FRACTION DECREASED (2 patients)
ERYSIPELAS (2 patients)
FACIAL PALSY (2 patients)
FEBRILE BONE MARROW APLASIA (2 patients)
FLATULENCE (2 patients)
GASTROENTERITIS (2 patients)
HAEMATOCRIT DECREASED (2 patients)
HYPERSENSITIVITY (2 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (2 patients)
INFECTION (2 patients)
KLEBSIELLA SEPSIS (2 patients)
LEUKOPENIA (2 patients)
LYMPHANGITIS (2 patients)
LYMPHOCYTE COUNT INCREASED (2 patients)
NERVOUS SYSTEM DISORDER (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
OEDEMA MUCOSAL (2 patients)
OTITIS MEDIA (2 patients)
PANCYTOPENIA (2 patients)
PARTIAL SEIZURES (2 patients)
PLATELET COUNT DECREASED (2 patients)
PULMONARY EMBOLISM (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE (2 patients)
RHINORRHOEA (2 patients)
SHOCK (2 patients)
STREPTOCOCCAL SEPSIS (2 patients)
SUDDEN CARDIAC DEATH (2 patients)
URTICARIA (2 patients)
ACCIDENTAL OVERDOSE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (1 patients)
AGITATION (1 patients)
ALVEOLITIS (1 patients)
ANOREXIA (1 patients)
ANXIETY (1 patients)
APHASIA (1 patients)
APHTHOUS STOMATITIS (1 patients)
ARACHNOIDITIS (1 patients)
BLOOD CULTURE POSITIVE (1 patients)
CALCULUS URINARY (1 patients)
CANDIDA SEPSIS (1 patients)
CANDIDIASIS (1 patients)
CARDIO-RESPIRATORY ARREST (1 patients)
CENTRAL NERVOUS SYSTEM LEUKAEMIA (1 patients)
CEREBRAL HAEMORRHAGE (1 patients)
CHEST PAIN (1 patients)
COLITIS (1 patients)
CONFUSIONAL STATE (1 patients)
COUGH (1 patients)
CYANOSIS (1 patients)
DIARRHOEA INFECTIOUS (1 patients)
DISEASE PROGRESSION (1 patients)
DISLOCATION OF VERTEBRA (1 patients)
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG TOXICITY (1 patients)
DRY SKIN (1 patients)
ENCEPHALOPATHY (1 patients)
EPILEPSY (1 patients)
ERYTHEMA (1 patients)
FLUSHING (1 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (1 patients)
GENERAL PHYSICAL CONDITION ABNORMAL (1 patients)
GRAFT VERSUS HOST DISEASE (1 patients)
HAEMATURIA (1 patients)
HEADACHE (1 patients)
HYPERBILIRUBINAEMIA (1 patients)
HYPERTENSIVE CRISIS (1 patients)
HYPOACUSIS (1 patients)
HYPOAESTHESIA (1 patients)
HYPOCALCAEMIA (1 patients)
HYPOMANIA (1 patients)
HYPOVOLAEMIC SHOCK (1 patients)
KLEBSIELLA INFECTION (1 patients)
LACTOSE INTOLERANCE (1 patients)
LEUKAEMIA PLASMACYTIC (1 patients)
METASTATIC NEOPLASM (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE MYELOMA (1 patients)
MUSCULAR WEAKNESS (1 patients)
MYALGIA (1 patients)
MYOGLOBIN BLOOD INCREASED (1 patients)
NEOPLASM (1 patients)
NEURALGIA (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PAIN (1 patients)
PARESIS (1 patients)
PNEUMONIA KLEBSIELLA (1 patients)
PNEUMONITIS (1 patients)
PRODUCTIVE COUGH (1 patients)
PRURITUS (1 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (1 patients)
PULMONARY HYPERTENSION (1 patients)
RADIUS FRACTURE (1 patients)
RASH GENERALISED (1 patients)
RASH MACULAR (1 patients)
RASH MACULO-PAPULAR (1 patients)
RENAL COLIC (1 patients)
RESPIRATORY DISTRESS (1 patients)
RIGHT VENTRICULAR DYSFUNCTION (1 patients)
SEPSIS (1 patients)
SKIN LESION (1 patients)
SPUTUM PURULENT (1 patients)
STAPHYLOCOCCAL BACTERAEMIA (1 patients)
STEM CELL TRANSPLANT (1 patients)
STOMATITIS (1 patients)
THROMBOSIS (1 patients)
THROMBOTIC MICROANGIOPATHY (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
ULNA FRACTURE (1 patients)
WEIGHT DECREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALIZAPRIDE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HYPERSENSITIVITY and ALIZAPRIDE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALIZAPRIDE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALIZAPRIDE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALIZAPRIDE experts. If you are a healthcare provider experienced in prescribing ALIZAPRIDE, please register here.

Your online appointment book for Paducah Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use